Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study

References

• Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000;15: 757–63.
   PubMed Web of Science ®Google Scholar
• Onyedum CC, Chukwuka JC. Admission profile and management of community acquired pneumonia in Nigeria – 5 year experience in a tertiary hospital. Respir Med 2011;105:298–302.
   PubMed Web of Science ®Google Scholar
• van Gageldonk-Lafeber AB, Wever PC, van der Lubben IM, de Jager CP, Meijer A, de Vries MC, et al. The aetiology of community-acquired pneumonia and implications for patient management. Neth J Med 2013;71:418–25.
   PubMed Web of Science ®Google Scholar
• Fiberesima FP, Onwuchekwa AC. Community acquired pneumonia in Port Harcourt Rivers State of Nigeria. Cent Afr J Med 2008;54:1–8.
   PubMedGoogle Scholar
• Menon RU, George AP, Menon UK. Etiology and anti- microbial sensitivity of organisms causing community acquired pneumonia: a single hospital study. J Family Med Prim Care 2013;2:244–9.
   PubMedGoogle Scholar
• Capelastegui A, España PP, Bilbao A, Gamazo J, Medel F, Salgado J, et al. Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes. BMC Infect Dis 2012;12:134.
   PubMed Web of Science ®Google Scholar
• Mandell LA. Epidemiology and etiology of community- acquired pneumonia. Infect Dis Clin North Am 2004;18: 761–76.
   PubMed Web of Science ®Google Scholar
• Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl 3):iii1–iii55.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–S72.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, et al. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med 2012;70:90–101.
   PubMed Web of Science ®Google Scholar
• Tamuno I, Mohammed IS. Self medication with antibiotics amongst students of a Nigerian tertiary institution. J Basic Appl Sci Res 2011;1:1319–26.
   Google Scholar
• Kehinde OO, Ogunnowo BE. The pattern of antibiotic use in an urban slum in Lagos State, Nigeria. West African Journal of Pharmacy 2013;24:49–57.
   Google Scholar
• National population commission. Report of the 2006 National census. Abuja, Nigeria.
   Google Scholar
• National Agency for the Control of AIDS (NACA). Global AIDS response country progress report. Nigeria GARPR 2012.
   Google Scholar
• Washington CW, Elmer WK, Koneman R, Stephen DA, Williams M. Koneman's colour atlas and textbook of diagnostic microbiology, 6th edn. Baltimore: Lippincott Williams & Wilkins; 2006. pp 431–52.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 10th edn. CLSI document M02-A10. Wayne PA: CLSI; 2009.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–81.
   PubMed Web of Science ®Google Scholar
• Lim WS, Van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining CAP severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377–82.
   PubMed Web of Science ®Google Scholar
• Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001;56:296–301.
   PubMed Web of Science ®Google Scholar
• Mermond S, Berlioz-Arthaud A, Estivals M, Baumann F, Levenes H, Martin PM. Aetiology of community-acquired pneumonia in hospitalized adult patients in New Caledonia. Trop Med Int Health 2010;15:1517–24.
   PubMed Web of Science ®Google Scholar
• Tao L, Hu B, He L, Wei L, Xie H, Wang B, et al. Etiology and antimicrobial resistance of community acquired pneumonia in adult patients in China. Chin Med J 2012; 125:2967–72.
   PubMed Web of Science ®Google Scholar
• Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56:109–14.
   PubMed Web of Science ®Google Scholar
• Nyamande K, Lalloo UG. Poor adherence to South African guidelines for the management of community-acquired pneumonia. S Afr Med J 2007;97:601–3.
   PubMed Web of Science ®Google Scholar
• Leesik H, Ani U, Juhani A, Altraja A. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia. Medicina (Kaunas) 2006;42:384–94.
   PubMedGoogle Scholar
• Musa BM, Tijjani BM, Okpapi JU, Borodo MM, Babashani M, Sheh Y. Bacterial isolates and antibiotic sensitivity in community acquired pneumonia. Niger Med J 2008;49:63–6.
   Google Scholar
• Bartlett JG, Mandy LM. Community-acquired pneumonia. N Engl J Med 1995;333:1618–24.
   PubMed Web of Science ®Google Scholar
• Rémond MG, Ralph AP, Brady SJ, Martin J, Tikoft E, Maguire GP. Community-acquired pneumonia in the central desert and north-western tropics of Australia. Intern Med J 2010;40:37–44.
   PubMed Web of Science ®Google Scholar
• Miyashita N, Fukano H, Mouri K, Fukuda M, Yoshida K, Kobashi Y, et al. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol 2005;54:395–400.
   PubMed Web of Science ®Google Scholar
• Koulla-Shiro S, Kuaban C, Bélec L. Microbial etiology of acute community-acquired pneumonia in adult hospitalized patients in Yaounde-Cameroon. Clin Microbiol Infect 1997;3:180–6.
   PubMedGoogle Scholar
• Liam CK, Lim KH, Wong CMM. Community acquired pneumonia in patients requiring hospitalisation. Respirology 2001;6:259–64.
   PubMedGoogle Scholar
• Woo JH, Kang JM, Kim YS, Shin WS, Ryu JH, Choi JH, et al. A prospective multicenter study of community-acquired pneumonia in adults with emphasis on bacterial etiology. Korean J Infect Dis 2001;33:1–7.
   Google Scholar
• Hooi LN, Looi I, Ng AJ. A study on community acquired pneumonia in adults requiring hospital admission in Penang. Med J Malaysia 2001;56:275–83.
   PubMedGoogle Scholar
• Chin Y, Loh L, Wong T, Muttalif AR. Sputum bacteriology and in-vitro antibiotic susceptibility in hospitalized patients with community acquired pneumonia in a state tertiary-referral hospital – a retrospective study. International e-Journal of Science, Medicine & Education (IeJSME) 2007;1:74–9.
   Google Scholar
• Ewig S, Torres A, Angeles Marcos M, Angrill J, Rañó A, de Roux A, et al. Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J 2002;20:1254–62.
   PubMed Web of Science ®Google Scholar
• British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993;49:346–50.
   PubMed Web of Science ®Google Scholar
• Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418–26.
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Breiman RF, Mandell LA, File TM. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998;26:811–38.
   PubMed Web of Science ®Google Scholar
• Zafar A, Hussain Z, Lomama E, Sibille S, Irfan S, Khan E. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan – the active study. J Ayub Med Coll Abbottabad 2008;20:7–9.
   PubMedGoogle Scholar
• Anagaw B, Gezachew M, Biadgelgene F, Anagaw B, Geleshe T, Taddese B, et al. Antimicrobial susceptibility patterns of Streptococcus pneumoniae over 6 years at Gondar University Hospital, Northwest Ethiopia. Asian Pac J Trop Biomed 2013;3:536–41.
   PubMedGoogle Scholar
• Sabes-Figuera R, Segu JL, Puig-Junoy J, Torres A. Influence of bacterial resistances on the efficiency of antibiotic treatments for community-acquired pneumonia. Eur J Health Econ 2008;9:23–32.
   PubMed Web of Science ®Google Scholar
• Nigerian Infectious Diseases Society. Guide to empiric antibiotic therapy for common severe bacterial infections in adults. NIDS 2013. Available at: http://nigerianidsociety.com/uploads/3/3/3/1/3331389/nids
   Google Scholar
• Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1–4. Ann Clin Microbiol Antimicrob 2008;7:1–11.
   PubMedGoogle Scholar
• Mokaddas EM, Rotimi VO, Albert MJ. Increasing prevalence of antimicrobial resistance in Streptococcus pneumoniae in Kuwait: implications for therapy. Microb Drug Resist 2007;13:227–33.
   PubMed Web of Science ®Google Scholar
• Derese D, Eskindir L, Araya G. Streptococcus pneumoniae and antimicrobial resistance Hawassa University Referral Hospital. J Med Lab Diagn 2011;2:27–30.
   Google Scholar
• Akanbi HAA, Taiwo SS, Babatunde SK, Onile BA, Abdulraheem IS. Antibiotic susceptibility pattern of Streptococcus pneumoniae in Ilorin, Nigeria. Afr J Clin Exp Microbiol 2004;5:173–6.
   Google Scholar
• Singh A. Fluoroquinolones should not be the first-line antibiotics to treat community-acquired pneumonia in areas of tuberculosis endemicity. Clin Infect Dis 2007;45:133, author reply 134–5.
   Web of Science ®Google Scholar
• Wang JY, Hsueh PR, Jan IS, Lee LN, Liaw YS, Yang PC, et al. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. Thorax 2006; 61:903–8.
   PubMed Web of Science ®Google Scholar